Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 360 Neoplasms 254 Prostatic Neoplasms 206 Colorectal Neoplasms 157 Lung Neoplasms 136 Carcinoma, Non-Small-Cell Lung 112 Leukemia, Myeloid, Acute 109 Pancreatic Neoplasms 99 Multiple Myeloma 93 Glioblastoma 80 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Brain Neoplasms 78 Head and Neck Neoplasms 77 Carcinoma, Hepatocellular 70 Melanoma 68 Squamous Cell Carcinoma of Head and Neck 66 Uterine Cervical Neoplasms 61 Ovarian Neoplasms 61 Neoplasm Metastasis 59 Rectal Neoplasms 53 Hematologic Neoplasms 53 Glioma 53 Stomach Neoplasms 50 Recurrence 49 Carcinoma, Renal Cell 49 Myelodysplastic Syndromes 47 Sarcoma 46 Motor Activity 46 Triple Negative Breast Neoplasms 44 Esophageal Neoplasms 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pelvic Pain × 30 days × Clear all

NCT05538689 2026-06-05

SOUL

University of Chicago

Phase 4 Withdrawn

Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡